In conclusion, we not only showed that PES1 had a tumor growth-promoting effect in pancreatic cancer but also demonstrated that combining Dinaciclib with JQ1 could inhibit tumor growth in mouse xenograft models. The gene discussed is PES1; the disease is pancreatic neoplasm.